Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings

Glucagon-like peptide-1 receptor agonists (GLP-1RA) have a more potent glycated hemoglobin (HbA1c)-lowering effect than existing therapies and are widely used for treating type 2 diabetes mellitus (T2DM). Once-daily oral semaglutide is the world’s first oral GLP-1RA. This study aimed to provide real...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Hodaka, Yoshida, Masashi, Funazaki, Shunsuke, Morimoto, Jun, Tonezawa, Shiori, Takahashi, Asuka, Nagashima, Shuichi, Masahiko, Kimura, Kiyoshi, Otsuka, Hara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141082/
https://www.ncbi.nlm.nih.gov/pubmed/37103055
http://dx.doi.org/10.3390/jcdd10040176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141082/
https://www.ncbi.nlm.nih.gov/pubmed/37103055
http://dx.doi.org/10.3390/jcdd10040176

Ejemplares similares